Pulmonary artery hypertension is characterized by proliferation in the resistance vessels. A recent study in Science Translational Medicine (Sutendra et al., 2010) found that increased fatty acid oxidation and a shift in the glycolysis/glucose oxidation ratio may be central to the pathogenesis of this process, suggesting that these abnormalities comprise novel treatment targets
Pulmonary arterial hypertension (PAH) is a devastating disease that is precipitated by hypertrophic ...
Pulmonary arterial hypertension (PAH) is a devastating disease that is precipitated by hypertrophic ...
Pulmonary hypertension (PH) is a complex, multifactorial disorder divided into five major subtypes a...
Pulmonary artery hypertension is characterized by proliferation in the resistance vessels. A recent ...
Pulmonary arterial hypertension (PAH) is a vascular remodeling disease of the lungs resulting in hea...
AbstractPulmonary arterial hypertension (PAH) has a multifactorial pathobiology. Vasoconstriction, r...
Pulmonary hypertension (PH) is an enigmatic vascular disorder characterized by pulmonary vascular re...
Knowledge of the pathobiology of pulmonary hypertension (PH) continues to accelerate. However, funda...
SIGNIFICANCE: The molecular events that promote the development of pulmonary hypertension (PH) are c...
SIGNIFICANCE: The molecular events that promote the development of pulmonary hypertension (PH) are c...
Pulmonary arterial hypertension (PAH) is a syndrome of dyspnea, fatigue, chest pain and syncope defi...
Vascular remodeling is considered a key event in the pathogenesis of pulmonary arterial hypertension...
Pulmonary arterial hypertension (PAH) describes a group of conditions with a common hemodynamic phen...
Knowledge of the pathobiology of pulmonary hypertension (PH) continues to accelerate. However, funda...
In order to intervene appropriately and develop disease-modifying therapeutics for pulmonary arteria...
Pulmonary arterial hypertension (PAH) is a devastating disease that is precipitated by hypertrophic ...
Pulmonary arterial hypertension (PAH) is a devastating disease that is precipitated by hypertrophic ...
Pulmonary hypertension (PH) is a complex, multifactorial disorder divided into five major subtypes a...
Pulmonary artery hypertension is characterized by proliferation in the resistance vessels. A recent ...
Pulmonary arterial hypertension (PAH) is a vascular remodeling disease of the lungs resulting in hea...
AbstractPulmonary arterial hypertension (PAH) has a multifactorial pathobiology. Vasoconstriction, r...
Pulmonary hypertension (PH) is an enigmatic vascular disorder characterized by pulmonary vascular re...
Knowledge of the pathobiology of pulmonary hypertension (PH) continues to accelerate. However, funda...
SIGNIFICANCE: The molecular events that promote the development of pulmonary hypertension (PH) are c...
SIGNIFICANCE: The molecular events that promote the development of pulmonary hypertension (PH) are c...
Pulmonary arterial hypertension (PAH) is a syndrome of dyspnea, fatigue, chest pain and syncope defi...
Vascular remodeling is considered a key event in the pathogenesis of pulmonary arterial hypertension...
Pulmonary arterial hypertension (PAH) describes a group of conditions with a common hemodynamic phen...
Knowledge of the pathobiology of pulmonary hypertension (PH) continues to accelerate. However, funda...
In order to intervene appropriately and develop disease-modifying therapeutics for pulmonary arteria...
Pulmonary arterial hypertension (PAH) is a devastating disease that is precipitated by hypertrophic ...
Pulmonary arterial hypertension (PAH) is a devastating disease that is precipitated by hypertrophic ...
Pulmonary hypertension (PH) is a complex, multifactorial disorder divided into five major subtypes a...